| Print
Fresenius Medical Care AG (FMS)
EquityOpen
$24.03
Previous close
$24.05
Trade high
$24.1199
Volume
274,779
Year high
$30.46
Year low
$22.05
Dividend yield
3.38%
Market capitalisation
$13.98 bn
P/E ratio
16.76
ISIN
US3580291066
This share can be held in a Dealing account
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 20/05/2024 | 23/05/2025 |
| Ex-dividend date | 17/05/2024 | 23/05/2025 |
| Payment date | 03/06/2024 | 06/06/2025 |
| Amount | $0.64284 | $0.81497 |
Company profile
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourthsof sales, while the balance is generated from medical technology products that enable dialysis treatments.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.